[1. G. M. Jantzen and J. R. Robinson, Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, 1996, pp. 575-610.]Search in Google Scholar
[2. S. Miyazaki, H. Aoyama, N. Kawasaki, W. Kubo and D. Attwood, In situ-gelling gellan formulations as vehicles for oral drug delivery, J. Control. Release 60 (1999) 287-295; DOI: 10.1016/ S0168-3659(99)00084-X.10.1016/S0168-3659(99)00084-X]Search in Google Scholar
[3. S. Miyazaki, W. Kubo and D. Attwood, Oral sustained delivery of theophylline using in situ gelation of sodium alginate, J. Control. Release 67 (2000) 275-280; DOI: 10.1016/s0168-3659(00) 00214-5.]Search in Google Scholar
[4. S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo and D. Attwood, Comparison of in situ gelling formulations for the oral delivery of cimetidine, Int. J. Pharm. 220 (2001) 161-168; DOI: 10.1016/ S0378-5173(01)00669-X.10.1016/S0378-5173(01)00669-X]Search in Google Scholar
[5. W. Kubo, S. Miyazaki and D. Attwood, Oral sustained delivery of paracetamol from in situ- -gelling gellan and sodium alginate formulations, Int. J. Pharm. 258 (2003) 55-64; DOI: 10.1016/ S0378-5173(03)00163-7.10.1016/S0378-5173(03)00163-7]Search in Google Scholar
[6. D. Schmaljohann, Thermo- and pH-responsive polymers in drug delivery, Adv. Drug Deliv. Rev. 58 (2006) 1655-1670; DOI: 10.1016/j.addr.2006.09.020.10.1016/j.addr.2006.09.02017125884]Search in Google Scholar
[7. T. Coviello, P. Matricardi, C. Marianecci and F. Alhaique, Polysaccharide hydrogels for modified release formulations, J. Control. Release 119 (2007) 5-24; DOI: S0168-3659(07)00039-9 [pii] 10.1016/j.jconrel.2007.01.004.]Search in Google Scholar
[8. G. Rohith, B. K. Sridhar and A. Srinatha, Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation, Acta Pharm. 59 (2009) 345-354; DOI: 10.2478/v10007-009-0021-z.10.2478/v10007-009-0021-z19819830]Search in Google Scholar
[9. L. Rodriguez, O. Caputo, M. Cini, C. Cavallari and R. Grecchi, In vitro release of theophylline from directly-compressed matrices containing methacrylic acid copolymers and/or dicalcium phosphate dehydrate, Farmaco 48 (1993) 1597-1604.]Search in Google Scholar
[10. L. S. da Fonseca, R. P. Silveira, A.M. Deboni, E. V. Benvenutti, T. M. Costa, S. S. Guterres and A. R. Pohlmann, Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs, Int. J. Pharm. 358 (2008) 292-295; DOI: S0378-5173(08)00118-X [pii] 10.1016/j.ijpharm.2008.02.005.]Search in Google Scholar
[11. E. F. Reynolds James, Dextromethorphan Hydrobromide, Royal Pharmaceutical Society, London, 1996, p. 1066.]Search in Google Scholar
[12. J. L. Bem and R. Peck, Dextromethorphan. An overview of safety issues, Drug Safety 7 (1992) 190-199.10.2165/00002018-199207030-000041503667]Search in Google Scholar
[13. E. S. Pender and B. R. Parks, Toxicity with dextromethorphan-containing preparations: a literature review and report of two additional cases, Pediatr. Emerg. Care 7 (1991) 163-165.]Search in Google Scholar
[14. G. M. El Maghraby, Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose, Sci. Pharm. 77 (2009) 401-417; DOI: 10.3797/scipharm.0901-08.10.3797/scipharm.0901-08]Search in Google Scholar
[15. F. K. Alanazi, M. El-Badry and I. A. Alsarra, Spray-dried HPMC microparticles of indomethacin impact of drug-polymer ratio and viscosity of the polymeric solution on dissolution, Saudi Pharm. J. 14 (2006) 100-107.]Search in Google Scholar
[16. G. M. El Maghraby, E. M. Elzayat and F. K. Alanazi, Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan, Drug Dev. Ind. Pharm. (2011); DOI: 10.3109/03639045.2011.634811.10.3109/03639045.2011.63481122092113]Search in Google Scholar
[17. P. S. Rajinikanth and B. Mishra, Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori, Drug Dev. Ind. Pharm. 34 (2008) 577-587; DOI: 10.1080/0363904070183181910.1080/0363904070183181918568907]Search in Google Scholar
[18. K. A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48-49.10.1111/j.2042-7158.1975.tb09378.x235616]Search in Google Scholar
[19. M. R. Louhaichi, S. Jebali, M. H. Loueslati, N. Adhoum and L. Monser, Simultaneous determination of pseudoephedrine, pheniramine, guaifenesin, pyrilamine, chlorpheniramine and dextromethorphan in cough and cold medicines by high performance liquid chromatography, Talanta 78 (2009) 991-997; DOI: 10.1016/j.talanta.2009.01.019.10.1016/j.talanta.2009.01.019]Search in Google Scholar
[20. F. Alanazi, H. Li, D. S. Halpern, S. Oie and D. R. Lu, Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains, Int. J. Pharm. 255 (2003) 189-197; DOI: S0378517303000887.10.1016/S0378-5173(03)00088-7]Search in Google Scholar
[21. M. Malladi, R. Jukanti, R. Nair, S. Wagh, H. S. Padakanti and A. Mateti, Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets, Acta Pharm. 60 (2010) 267-280; DOI: 10.2478/v10007-010-0025-8.10.2478/v10007-010-0025-8]Search in Google Scholar
[22. R. P. Raffin, D. Jornada, S. Haas, A. R. Pohlmann and S. S. Guterres, “Pantoprazole sodium loaded controlled release microparticles,” in 15th International Symposium on Microencapsulation, Parma, ed. (Italy, 2005), pp. 7-8.]Search in Google Scholar
[23. K. H. Kim, M. J. Frank and N. L. Henderson, Application of differential scanning calorimetry to the study of solid drug dispersions, J. Pharm. Sci. 74 (1985) 283-289.10.1002/jps.2600740312]Search in Google Scholar
[24. R. J. Fessenden and J. S. Fessenden, Fessenden and Fessenden Organic Chemistry, Brooks/Cole publishing company, Pacific Grove, 1990, pp. 323-390. ]Search in Google Scholar
[25. Technical Information on EUDRAGIT L 100 and EUDRAGIT S 100, http://eudragit.evonik.com/product/eudragit/Documents/evonik-specification-eudragit-l-100-and-s-100.pdf; access date January 10, 2011.]Search in Google Scholar
[26. M. R. Jenquin and J. W. McGinity, Characterization of acrylic resin matrix films and mechanisms of drug-polymer interaction, Int. J. Pharm. 101 (1994) 23-24.10.1016/0378-5173(94)90072-8]Search in Google Scholar
[27. K. O. R. Lehman, Chemistry and Application Properties of Polymethacrylate Coating Systems, Informa Healthcare USA, Inc., New York, 1990, pp. 101-174.]Search in Google Scholar
[28. B. J. Lee, J. H. Cui, T. W. Kim, M. Y. Heo and C. K. Kim, Biphasic release characteristics of dual drug-loaded alginate beads, Arch. Pharm. Res. 21 (1998) 645-650.10.1007/BF02976751]Search in Google Scholar
[29. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspension, J. Pharm. Sci. 50 (1961) 874-875.10.1002/jps.2600501018]Search in Google Scholar
[30. G. M. Jantzen and J. R. Robinson, Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, 1996, pp. 575-610.]Search in Google Scholar
[31. S. Miyazaki, H. Aoyama, N. Kawasaki, W. Kubo and D. Attwood, In situ-gelling gellan formulations as vehicles for oral drug delivery, J. Control. Release 60 (1999) 287-295; DOI: 10.1016/ S0168-3659(99)00084-X.10.1016/S0168-3659(99)00084-X]Search in Google Scholar
[32. S. Miyazaki, W. Kubo and D. Attwood, Oral sustained delivery of theophylline using in situ gelation of sodium alginate, J. Control Release 67 (2000) 275-280; DOI: 10.1016/s0168-3659(00)00214-5.10.1016/S0168-3659(00)00214-5]Search in Google Scholar
[33. S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo and D. Attwood, Comparison of in situ gelling formulations for the oral delivery of cimetidine, Int. J. Pharm. 220 (2001) 161-168; DOI: 10.1016/ S0378-5173(01)00669-X.10.1016/S0378-5173(01)00669-X]Search in Google Scholar
[34. W. Kubo, S. Miyazaki and D. Attwood, Oral sustained delivery of paracetamol from in situ- -gelling gellan and sodium alginate formulations, Int. J. Pharm. 258 (2003) 55-64; DOI: 10.1016/ S0378-5173(03)00163-7.10.1016/S0378-5173(03)00163-7]Search in Google Scholar
[35. D. Schmaljohann, Thermo- and pH-responsive polymers in drug delivery, Adv. Drug Deliv. Rev. 58 (2006) 1655-1670; DOI: 10.1016/j.addr.2006.09.020.10.1016/j.addr.2006.09.020]Search in Google Scholar
[36. T. Coviello, P. Matricardi, C. Marianecci and F. Alhaique, Polysaccharide hydrogels for modified release formulations, J. Control. Release 119 (2007) 5-24; DOI: S0168-3659(07)00039-9 [pii] 10.1016/j.jconrel.2007.01.004.]Search in Google Scholar
[37. G. Rohith, B. K. Sridhar and A. Srinatha, Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation, Acta Pharm. 59 (2009) 345-354; DOI: 10.2478/v10007-009-0021-z.10.2478/v10007-009-0021-z]Search in Google Scholar
[38. L. Rodriguez, O. Caputo, M. Cini, C. Cavallari and R. Grecchi, In vitro release of theophylline from directly-compressed matrices containing methacrylic acid copolymers and/or dicalcium phosphate dehydrate, Farmaco 48 (1993) 1597-1604.]Search in Google Scholar
[39. L. S. da Fonseca, R. P. Silveira, A.M. Deboni, E. V. Benvenutti, T. M. Costa, S. S. Guterres and A.]Search in Google Scholar
[R. Pohlmann, Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs, Int. J. Pharm. 358 (2008) 292-295; DOI: S0378-5173(08) 00118-X [pii] 10.1016/j.ijpharm.2008.02.005.]Search in Google Scholar
[40. E. F. Reynolds James, Dextromethorphan Hydrobromide, Royal Pharmaceutical Society, London, 1996, p. 1066.]Search in Google Scholar
[41. J. L. Bem and R. Peck, Dextromethorphan. An overview of safety issues, Drug Safety 7 (1992) 190-199.10.2165/00002018-199207030-00004]Search in Google Scholar
[42. E. S. Pender and B. R. Parks, Toxicity with dextromethorphan-containing preparations: a literature review and report of two additional cases, Pediatr. Emerg. Care 7 (1991) 163-165.]Search in Google Scholar
[43. G. M. El Maghraby, Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose, Sci. Pharm. 77 (2009) 401-417; DOI: 10.3797/scipharm.0901-08. 10.3797/scipharm.0901-08]Search in Google Scholar
[44. F. K. Alanazi, M. El-Badry and I. A. Alsarra, Spray-dried HPMC microparticles of indomethacin impact of drug-polymer ratio and viscosity of the Polymeric solution on dissolution, Saudi Pharm. J. 14 (2006) 100-107.]Search in Google Scholar
[45. G. M. El Maghraby, E. M. Elzayat and F. K. Alanazi, Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan, Drug Dev. Ind. Pharm. (2011); DOI: 10.3109/03639045.2011.634811.10.3109/03639045.2011.634811]Search in Google Scholar
[46. P. S. Rajinikanth and B. Mishra, Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori, Drug Dev. Ind. Pharm. 34 (2008) 577-587; DOI: 10.1080/03639040701831819.10.1080/03639040701831819]Search in Google Scholar
[47. K. A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48-49.10.1111/j.2042-7158.1975.tb09378.x]Search in Google Scholar
[48. M. R. Louhaichi, S. Jebali, M. H. Loueslati, N. Adhoum and L. Monser, Simultaneous determination of pseudoephedrine, pheniramine, guaifenesin, pyrilamine, chlorpheniramine and dextromethorphan in cough and cold medicines by high performance liquid chromatography, Talanta 78 (2009) 991-997; DOI: 10.1016/j.talanta.2009.01.019.10.1016/j.talanta.2009.01.019]Search in Google Scholar
[49. F. Alanazi, H. Li, D. S. Halpern, S. Oie and D. R. Lu, Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains, Int. J. Pharm. 255 (2003) 189-197; DOI: S0378517303000887.10.1016/S0378-5173(03)00088-7]Search in Google Scholar
[50. M. Malladi, R. Jukanti, R. Nair, S. Wagh, H. S. Padakanti and A. Mateti, Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets, Acta Pharm. 60 (2010) 267-280; DOI: 10.2478/v10007-010-0025-8.10.2478/v10007-010-0025-8]Search in Google Scholar
[51. R. P. Raffin, D. Jornada, S. Haas, A. R. Pohlmann and S. S. Guterres, Pantoprazole sodiumloaded controlled release microparticles, in 15th International Symposium on Microencapsulation, Parma, ed. (Italy, 2005), pp. 7-8.]Search in Google Scholar
[52. K. H. Kim, M. J. Frank and N. L. Henderson, Application of differential scanning calorimetry to the study of solid drug dispersions, J. Pharm. Sci. 74 (1985) 283-289.10.1002/jps.2600740312]Search in Google Scholar
[53. R. J. Fessenden and J. S. Fessenden, Fessenden and Fessenden Organic Chemistry, Brooks/Cole publishing company, Pacific Grove, 1990, pp. 323-390.]Search in Google Scholar
[54. Technical Information on EUDRAGIT L 100 and EUDRAGIT S 100, http://eudragit.evonik.com/product/eudragit/Documents/evonik-specification-eudragit-l-100-and-s-100.pdf; access date January 10, 2011.]Search in Google Scholar
[55. M. R. Jenquin and J. W. McGinity, Characterization of acrylic resin matrix films and mechanisms of drug-polymer interaction, Int. J. Pharm. 101 (1994) 23-24.10.1016/0378-5173(94)90072-8]Search in Google Scholar
[56. K. O. R. Lehman, Chemistry and application properties of polymethacrylate coating systems, Informa Healthcare USA, Inc., New York, 1990, pp. 101-174.]Search in Google Scholar
[57. B. J. Lee, J. H. Cui, T. W. Kim, M. Y. Heo and C. K. Kim, Biphasic release characteristics of dual drug-loaded alginate beads, Arch Pharm. Res. 21 (1998) 645-650.10.1007/BF029767519868531]Search in Google Scholar
[58. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspension, J. Pharm. Sci. 50 (1961) 874-875. 10.1002/jps.260050101813907269]Search in Google Scholar